首页> 外国专利> MIRNA CLASSIFIER FOR DIAGNOSING LYMPH NODE METASTASIS OF COLORECTAL CANCER AND METHOD FOR DIAGNOSING LYMPH NODE METASTASIS FROM COLORECTAL CANCER USING SAME

MIRNA CLASSIFIER FOR DIAGNOSING LYMPH NODE METASTASIS OF COLORECTAL CANCER AND METHOD FOR DIAGNOSING LYMPH NODE METASTASIS FROM COLORECTAL CANCER USING SAME

机译:用于诊断大肠癌淋巴结转移的miRNA分类器和使用大肠癌从大肠癌诊断淋巴结转移的方法

摘要

The present invention provides a 3-miRNA classifier of miR-342-3p, miR-3621, and miR361-3p as a miRNA classifier for diagnosing lymph node metastasis of a colorectal cancer and a method for diagnosing lymph node metastasis from a colorectal cancer using the same. According to the present invention, the miR-342-3p and the miR361-3p among the 3-miRNA classifier are controlled downward in comparison with LNM negative in CRC of LNM positive, and the miR-3621 is controlled upwards in comparison with the lymph node metastasis negative in CRC of the lymph node metastasis positive so that the 3-miRNA classifier can be used as a biomarker for determining the lymph node metastasis from the colorectal cancer. Also, E2F1, RAP2B, FOXM1, PIK3R3, AKT1, and WINT5A which are a protein revealed from a target gene of the miR-342-3p, the miR-361-3p, or miR-3621 are also significantly revealed and increased in the CRC of the lymph node metastasis positive. So, the 3-miRNA classifier can be used as the biomarker for determining the lymph node metastasis from the colorectal cancer. According to the present invention, in a case the protein revealed from the target gene and the 3-miRNA classifier is used as the biomarker, whether the lymph node metastasis from the colorectal cancer at an early stage occurs can be accurately and rapidly determined. So, the number of unnecessary additional surgeries to the T1-stage CRC enabling surgical removal by endoscope can be reduced. Therefore, the miRNA classifier is effective.;COPYRIGHT KIPO 2018
机译:本发明提供了miR-342-3p,miR-3621和miR361-3p的3-miRNA分类器,作为用于诊断结直肠癌的淋巴结转移的miRNA分类器,以及使用该方法从大肠癌诊断淋巴结转移的方法。相同。根据本发明,3-miRNA分类器中的miR-342-3p和miR361-3p与LNM阳性的CRC中的LNM阴性相比被向下控制,并且miR-3621与淋巴液中的相比被向上控制。淋巴结转移的CRC阳性的淋巴结转移阴性,因此3-miRNA分类器可用作确定大肠癌淋巴结转移的生物标志物。另外,从miR-342-3p,miR-361-3p或miR-3621的靶基因揭示的蛋白质E2F1,RAP2B,FOXM1,PIK3R3,AKT1和WINT5A也显着地表达并增加。 CRC的淋巴结转移阳性。因此,3-miRNA分类器可用作确定大肠癌淋巴结转移的生物标志物。根据本发明,在将从靶基因和3-miRNA分类器揭示的蛋白质用作生物标记物的情况下,可以准确且快速地确定早期是否发生了大肠癌的淋巴结转移。因此,可以减少T1期CRC不必要的额外手术的数量,从而可以通过内窥镜进行手术切除。因此,miRNA分类器是有效的。; COPYRIGHT KIPO 2018

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号